Topotecan (T) vs. Observation (OB) Following Cisplatin (P) Plus Etoposide (E) in Extensive Stage Small Cell Lung Cancer (ES SCLC) (E7593): A Phase III Trial of the Eastern Cooperative Oncology Group (ECOG)

Diana Stripp, MD
OncoLink Assistant Editor
Ultima Vez Modificado: 22 de mayo del 2000

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016